Further Rationales for Holistic Approaches to Treating MASH & Metabolic Diseases
Time: 1:45 pm
day: Conf Day 2 PM
Details:
- Brief overview of epidemiology and risk factors in MASH and metabolic diseases including the added risks when multiple metabolic diseases are present
- Discuss the preliminary benefits observed in metabolic and hepatic endpoints in Phase 2 studies of berberine ursodeoxycholate
